Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on August 29, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Par Drugs and Chemicals Limited met on August 29, 2025 and approved several items. The 26th Annual General Meeting (AGM) has been scheduled for Saturday, September 27, 2025 at 11:00 AM in Vadodara, Gujarat, with remote e-voting from September 23-26, 2025 and book closure from September 20-27, 2025. The Board approved the Directors Report for FY ended March 31, 2025 and recommended re-appointment of Mr. Falgun Vallabhbhai Savani (Chairman & MD) by rotation, subject to shareholder approval. It also approved Rs. 24 Lakhs annual remuneration for Independent Director Mr. Pravin Bhayani and re-appointed Mrs. Bintal Bhaveshkumar Shah as Independent Director for a second 5-year term (Sept 2025 to Sept 2030). New Statutory Auditor M/s. Sarupria Somani & Associates was appointed for FY 2025-26 at fees of Rs. 2.25 Lakhs, along with re-appointments of Internal, Secretarial (5-year term through FY 2029-30), and Cost Auditors. The Board also approved purchase of a Tata Harrier automatic vehicle worth approximately Rs. 29.30 Lakhs for CEO Mr. Jignesh Savani's official use.
This is a routine pre-AGM board outcome with no major material events such as fundraising, dividend, M&A, or significant capital expenditure. Most decisions including director re-appointments and auditor appointments require shareholder approval at the upcoming AGM on September 27, 2025. The vehicle purchase for CEO use is a minor expense and unlikely to materially impact the stock.